Braskem (NYSE:BAK - Get Free Report) is expected to release its Q2 2025 earnings results before the market opens on Thursday, August 14th. Analysts expect Braskem to post earnings of ($0.27) per share for the quarter.
Braskem (NYSE:BAK - Get Free Report) last released its quarterly earnings results on Monday, May 12th. The company reported $0.30 EPS for the quarter, beating analysts' consensus estimates of $0.03 by $0.27. The business had revenue of $3.60 billion for the quarter, compared to the consensus estimate of $22.86 billion. On average, analysts expect Braskem to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Braskem Stock Performance
Shares of BAK stock opened at $3.15 on Thursday. Braskem has a fifty-two week low of $2.85 and a fifty-two week high of $7.71. The firm has a market cap of $1.25 billion, a P/E ratio of -0.75 and a beta of 1.70. The business's 50 day moving average price is $3.44 and its 200-day moving average price is $3.76.
About Braskem
(
Get Free Report)
Braskem SA, together with its subsidiaries, produces and sells thermoplastic resins. The company operates through three segments: Brazil, United States and Europe, and Mexico. The Brazil segment produces and sells olefins, including ethylene, polymer and chemical grade propylene, butadiene, and butene-1; benzene, toluene, and xylenes products; fuels, such as automotive gasoline, liquefied petroleum gas, ethyl tertiary-butyl ether, and methyl tertiary-butyl ether; intermediates, such as cumene; aliphatics, aromatics, and hydrogenated solvents; and specialties comprising isoprene, dicyclopentadiene, piperylene, nonene, tetramer, polyisobutylene, and hydrocarbon resins.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Braskem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Braskem wasn't on the list.
While Braskem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.